PA
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.526
Exchange
XNAS - Nasdaq
1.37
Last period Debt / Equity ratio ,USD
864%
Debt / Equity ratio has increased in 5 years
What is Debt / Equity ratio ?
Debt / Equity ratio is the volume of debt obligations to the equity of the company. The value of 0.5 is the benchmark for Eyestock Rating calculation.
See also Pacific Biosciences
Company Analysis
PACB valuation, rating, competitors, insights and company profile
Eyestock Rating
PACB financial analysis by Eyestock methodology
Valuation
PACB valuation using historical relative method
Statements
PACB Income Statements, Balance Sheet and Cash Flow Statements
Dividends
PACB dividend yield and annual dividend
Debt / Equity ratio is the volume of debt obligations to the equity of the company. The value of 0.5 is the benchmark for Eyestock Rating calculation.
Pacific Biosciences`s Debt / Equity ratio for the last twelve months ended 2024-06-30 is 1.37
